Exploration of exercise intolerance by 31P NMR spectroscopy of calf muscles coupled with MRI and ergometry;Exploration de l'intolérance à l'exercice par spectroscopie RMN du phosphore des muscles fléchisseurs plantaires

Revue Neurologique

Volumn 159, Issue 1, 2003, Pages 56-67

  Laforet P ^a   Wary, C ^a   Duteil, S ^a   De Kerviler, E ^b   Carlier, P G ^a   Lombes A ^a   Romero, N B ^a   Fardeau, M ^a   Eymard, B ^a   Leroy Willig, A ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b SAINT LOUIS HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CARNITINE PALMITOYLTRANSFERASE; CREATINE KINASE; CREATINE PHOSPHATE;

ADOLESCENT; ADULT; AGED; AMINO ACID SYNTHESIS; ARTICLE; CELL PH; CHILD; CONTROLLED STUDY; ENZYME DEFICIENCY; ERGOMETRY; EXERCISE TEST; EXERCISE TOLERANCE; FEMALE; FLEXOR MUSCLE; GASTROCNEMIUS MUSCLE; GLYCOGEN STORAGE DISEASE; GLYCOGENOLYSIS; GLYCOLYSIS; HUMAN; HUMAN TISSUE; LEG; MAJOR CLINICAL STUDY; MALE; MITOCHONDRIAL MYOPATHY; MUSCLE BIOPSY; MUSCULAR DYSTROPHY; MYOPATHY; NUCLEAR MAGNETIC RESONANCE IMAGING; OVEREXERTION; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; RHABDOMYOLYSIS; SENSITIVITY AND SPECIFICITY; SYMPTOMATOLOGY;

ADOLESCENT; ADULT; AGED; EXERCISE; EXERCISE TEST; EXERCISE TOLERANCE; FEMALE; GLYCOGEN; GLYCOLYSIS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MUSCLE, SKELETAL; PHOSPHOCREATINE; RHABDOMYOLYSIS;

EID: 1542291716     PISSN: 00353787     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. 31P-NMR spectroscopy and the metabolic properties of different muscle fibers. J Appl Physiol, 68: 644-649.
2. ARGOV Z, BANK W, MARIS J, CHANCE B. (1987a). Muscle energy metabolism in McArdle's syndrome by in vivo phosphorus magnetic resonance spectroscopy. Neurology, 37: 1720-1724.
3. ARGOV Z, BANK W, MARIS J, LEIGH J, CHANCE B. (1987a). Muscle energy metabolism in human PFK deficiency as recorded by 31P NMR spectroscopy. Ann Neurol, 22: 46-51.
4. ARGOV Z, BANK W, MARIS J, PETERSON P, CHANCE B. (1987). Bioenergetic heterogeneity of human mitochondrial myopathies: phosphorus magnetic resonance spectroscopic study. Neurology, 37: 257-262.
5. ARGOV Z, DESTEFANO N, ARNOLD D. (1996). ADP recovery after a brief ischemic exercise in normal and diseased human musclea 31P MRS study. NMR in biomedicine, 9: 165-172.
6. ARGOV Z, LÖFBERG M, ARNOLD D. (2000). Insight into muscle diseases gained by phosphorus magnetic resonance spectroscopy. Muscle & Nerve, 23: 1316-1324.
7. ARNOLD DL, MATTHEWS PM, RADDA GK. (1984). Metabolic recovery after exercise and the assessment of mitochondrial function in vivo in human skeletal muscle by means of 31P NMR. Magn Reson Med, 1: 307-315.
8. BARBIROLI B, FRASSINETI C, MARTINELLI P, et al. (1997). Coenzyme Q (10) improves mitochondrial respiration in patients with mitochondrial cytopathies. An in vivo study on brain and skeletal muscle by phosphorus magnetic resonance spectroscopy. Cell Mol Biol, 43: 741-749.
9. BARBIROLI B, FUNICELLO R, IOTTI S, MONTAGNA P, FERLINI A, ZANIOL P. (1992). 31P-NMR spectroscopy of skeletal muscle in Becker dystrophy and DMD/BMD carriers. Altered rate of phosphate transport. J Neurol Sci, 109: 188-195.
10. BENDAHAN D, CONFORT GS, KOZAK RG, COZZONE PJ. (1992). 31-P NMR characterization of the metabolic anomalies associated with the lack of glycogen phosphorylase activity in human forearm muscle. Biochem Biophys Res Commun, 185: 16-21.
11. BENDAHAN D, CONFORT-GOUNY S, KOZAC-RIBBENS G, COZZONE PJ. (1993). Investigation of metabolic myopathies by P-31 MRS using a standardized rest-exercise-recovery protocol: a survey of 800 explorations. MAGMA, 1: 91-104.
12. BRILLAULT-SALVAT C, GIACOMINI E, WARY C, et al. (1997). An interleaved heteronuclear NMRI-NMRS approach to non-invasive investigation of exercising human skeletal muscle. Cell Mol Biol, 43: 751-753.
13. CHAUSSAIN M, CAMUS F, DEFOLIGNY C, EYMARD B, FARDEAU M. (1992). Respiratory and metabolic data of a maximal exercise test in patients with exercise intolerance in McArdle's disease and mitochondrial myopathies. Eur J Med, 1: 457-463.
14. CHILIBECK P, MCCREARY C, MARSH G, et al. (1998). Evaluation of muscle oxidative potential by 31P-MRS during incremental exercise in old and young humans. Eur J Appl Physiol, 78: 460-465.
15. DE KERVILER E, LEROY-WILLIG A, DUBOC D, EYMARD B, SYROTA A. (1996). MR quantification of muscle fatty replacement in muscular glycogenoses. Mag Res Imaging, 14: 1137-1141.
16. DE STEFANO N, ARGOV Z, MATTHEWS P, KARPATI G, ARNOLD D. (1996). Impairment of muscle mitochondrial oxidative metabolism in McArdle's disease. Muscle Nerve, 19: 764-769.
17. DUBOC D, JEHENSON P, TRAN DINH S, MARSAC C, SYROTA A, FARDEAU M. (1987). Phosphorus NMR spectroscopy study of muscular enzyme deficiencies involving glycogenosis and glycolysis. Neurology, 37: 663-671.
18. ELLIOT D, BUIST N, GOLDBERG L, KENNAWAY N, POWELL B, KUEHL K. (1989). Metabolic myopathies: evaluation by graded exercise testing. Medicine (Baltimore), 68: 163-172.
19. FIGARELLA-BRANGER D, KOZAK RG, RODET L, et al. (1993). Pathological findings in 165 patients explored for malignant hyperthermia susceptibility. Neuromuscul Disord, 3: 553-556.
20. FLECKENSTEIN J, REIMERS C, HALLER R. Inherited defects of muscle energy metabolism: radiologic evaluation. In: FLECKENSTEIN J, CRUES J, REIMERS C (eds). Muscle imaging in health and disease. New York, Springer-Verlag, 1996. p.253-267.
21. FOWLER MD, RYSCHON TW, WYSONG RE, COMBS CA, BALABAN RS. (1997). Normalized metabolic stress for P31-MR spectroscopy studies of human skeletal muscle: MVC vs. muscle volume. J Appl Physiol, 83: 875-883.
22. GHERARDI RK, COQUET M, CHERIN P, et al. (1998). Macrophagic myofasciitis: an emerging entity. Groupe d'Etudes et Recherche sur les Maladies Musculaires Acquises et Dysimmunitaires (GERMMAD) de l'Association Française contre les Myopathies (AFM). Lancet, 352: 347-352.
23. GOSPE SM Jr., LAZARO RP, LAVA NS, GROOTSCHOLTEN PM, SCOTT MO, FISCHBECK KH. (1989). Familial X-linked myalgia and cramps: a nonprogressive myopathy associated with a deletion in the dystrophin gene. Neurology, 39: 1277-1280.
24. HOGREL JY, LAFORÉT P, BEN YAOU R, CHEVROT M, EYMARD B, LOMBES A. (2001). A non-ischemic forearm exercise test for the screening of patients with exercise intolerance. Neurology, 56: 1733-1738.
25. IOTTI S, LODI R, FRASSINETI C, ZANIOL P, BARBIROLI B. (1993). In vivo assessment of mitochondrial functionality in human gastrocnemius muscle by 31P MRS. NMR in biomedicine, 6: 248-253.
26. KEMP GJ, TAYLOR DJ, THOMPSON CH, et al. (1993). Quantitative analysis by 31P magnetic resonance spectroscopy of abnormal mitochondrial oxydation in skeletal muscle during recovery from exercise. NMR in biomedicine, 6: 302-310.
27. KUHL C, LAYER G, TRABER F, ZIERZ S, BLOCK W, REISER M. (1994). Mitochondrial encephalopathy: correlation of P-31 exercise MR spectroscopy with clinical findings. Radiology, 192: 223-230.
28. LODI R, MUNTONI F, TAYLOR J, et al. (1997a). Correlative MR imaging and 31P-NMR spectroscopy in sarcoglycan deficient limb girdle muscular dystrophy. Neuromuscul Disord, 7: 505-511.
29. LODI R, TAYLOR D, RADDA G. (1997a). Chronic fatigue syndrome and skeletal muscle mitochondrial function. Muscle Nerve, 20: 765-766.
30. LODI R, TAYLOR DJ, TABRIZI SJ, et al. (1998). Normal in vivo skeletal muscle oxidative metabolism in sporadic inclusion body myositis assessed by P-31-magnetic resonance spectroscopy. Brain, 121: 2119-2126.
31. MC ARDLE B, VEREL D. (1956). Responses to ischemic work in the human forearm. Clin Sci, 15: 302-318.
32. MILLS K, EDWARDS R. (1983). Investigative strategies for muscle pain. J Neurol Sci, 58: 73-88.
33. MOON R, RICHARDS J. (1973). Determination of intracellular pH by 31P magnetic resonance. J Biol Chem, 248: 7276-7278.
34. PARK JH, BROWN RL, PARK CR, et al. (1987). Functional pools of oxydative and glycolytic fibers in human muscle observed by 31P magnetic resonance spectroscopy during exercise. Proc Natl Acad Sci, 84: 8976-8980.
35. TARTAGLIA M, CHEN J, CARAMANOS Z, TAIVASSALO T, ARNOLD D, ARGOV Z. (2000). Muscle phosphorus magnetic resonance spectroscopy oxidative indices correlate with physical activity. Muscle Nerve, 23: 175-181.
36. TAYLOR D, KEMP G, THOMPSON C, RADDA G. (1997). Ageing: effects on oxydative function of skeletal muscle in vivo. Moll Cell Biochem, 174: 321-324.
37. TAYLOR DJ, KEMP GJ, WOODS CG, EDWARDS JH, RADDA GK. (1993). Skeletal Muscle Bioenergetics in Myotonic Dystrophy. J Neurol Sci, 116: 193-200.
38. WALKER P, BRUNOTTE F, ROUHIER-MARCER I, et al. (1998). Nuclear magnetic resonance evidence of different muscular adaptations after resistance training. Arch Phys Med Rehabil, 79: 1391-1398.